Analyst Ratings for Adamis Pharma (DMK)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/7/2023 | Maxim Group | Michael Okunewitch | New Coverage | Buy (N/A) |
1.50 (N/A) |
0.61 (0.23) |
-62.3% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/7/2023 | Maxim Group | Michael Okunewitch | New Coverage | Buy (N/A) |
1.50 (N/A) |
0.61 (0.23) |
-62.3% | Details |